Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...

Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ...

Hims wasn’t stepping back enough from its practice of mass marketing compounded versions of the weight-loss medicine, said ...

The calming in the oil market came as several analysts said Iran would likely refrain from closing the waterway. Iran itself ...

The S&P 500 closed higher on Thursday, lifted by a rally in Oracle shares and a favorable inflation report. The benchmark ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...